Ophthalmic Photocoagulator Market Size to Worth Around USD 313.2 Mn by 2030

The global Ophthalmic Photocoagulator market size was reached at USD 180.6 billion in 2020 and is projected to surpass US$ 313.2 million by 2030, expanding growth at a CAGR of 10.7% from 2021 to 2030.

Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38415

Growth Factors

The global influence of COVID-19 on eye health and the rise in the incidence of increasing ocular diseases, such as and age-related macular edema, are the key factors fuelling the market growth.

The growing elderly population and the increasing prevalence of diabetes-related blindness are also projected to fuel the market growth. Various eye diseases are quite frequent in the geriatric population. The National Institute on Aging (NIA) estimated that the elderly population would reach 72 million people by 2030. Diabetic retinopathy has become more common as the diabetic epidemic has spread throughout the world. Individuals’ average time spent on a digital screen has risen, resulting in a variety of eye-related pain and disorders. 

Report Highlights

The diabetic retinopathy segment held the largest share of 38.2% in 2020 and is expected to grow at the fastest rate over the forecast period. The prevalence rate as per the American Academy of Ophthalmology, 2019 for retinopathy for all adults with diabetes aged 40 worldwide has been estimated at 34.6% (93 million people).

The green scan laser photocoagulator segment dominated the market and held a share of 43.4% in 2020. The green laser wavelength (532 nm) is considered to be a standard laser as it offers versatile applications and excellent absorption.

The multicolor scan laser photocoagulator segment is expected to grow at the fastest rate of 10.3% during the forecast period. The multicolor scan laser allows the selection of multiple wavelengths in one versatile machine, making it easier for the surgeons. 577 nm yellow, 532 nm green, and 647 nm red are the most often used wavelengths and combinations of any two or all three wavelengths at the same time

Hospitals held the largest share of 46.4% in 2020 due to the extensive use of ophthalmic lasers in hospital settings. Furthermore, the growing number of hospitals in emerging countries, the improvement of existing eye care infrastructure at government medical colleges and district hospitals, and the construction of new eye care infrastructure are expected to aid the segment growth.

North America dominated the market by capturing a share of 444.0% in 2020. Chronic eye illnesses such as age-related macular edema, diabetic retinopathy, and glaucoma are becoming more common as a result of high stress and unhealthy lifestyles, which are high-impact key drivers for the North American market. According to the International Diabetes Federation (IDF), the U.S. has the highest diabetes rate among 38 developed countries, with approximately 30 million people suffering from the disease.

Asia Pacific is expected to grow at the fastest rate of 10.9% during the forecast period. The increasing incidence of optical diseases, which includes glaucoma, age-related macular degeneration, and diabetic retinopathy, is creating a demand for photocoagulation in this region.

Report Coverage Details
Market Size US$ 313.2 million by 2030
Growth Rate CAGR of 10.7% From 2021 to 2030
Base Year 2020
Historic Data 2017 to 2020
Forecast Period 2021 to 2030
Segments Covered Application, Wavelength, End use
Regional Scope North America, Latin America, Europe, Asia Pacific, MEA
Companies Mentioned Lumenis; IRIDEX Corporation; Alcon Inc.; Quantel Medical; NIDEK CO., LTD.; Johnson & Johnson Vision Care, Inc.; TOPCON CORPORATION; Bausch & Lomb Incorporated; Meridian Medical Group

Key Players

  • Lumenis
  • IRIDEX Corporation
  • Alcon Inc.
  • Quantel Medical
  • NIDEK CO., LTD.
  • Johnson & Johnson Vision Care, Inc.
  • TOPCON CORPORATION
  • Bausch & Lomb Incorporated
  • Meridian Medical Group

Market Segmentation

  • Application Outlook
    • Glaucoma
    • Diabetic Retinopathy
    • Age-related Macular Degeneration
    • Macular Edema
    • Others
  • Wavelength Outlook
    • Green Scan Laser Photocoagulator
    • Yellow Scan Laser Photocoagulator
    • Red Scan Laser Photocoagulator
    • Multicolor Scan Laser Photocoagulator
  • End-use Outlook
    • Hospitals
    • Ambulatory Surgery Centers
    • Ophthalmology Clinics
  • Regional Outlook
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
    • Asia Pacific
      • Japan
      • China
      • India
      • Thailand
      • South Korea
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Colombia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38415

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Ophthalmic Photocoagulator Market, By Application

7.1.  Ophthalmic Photocoagulator Market, by Application, 2021-2030

7.1.1.    Glaucoma

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Diabetic Retinopathy

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    Age-related Macular Degeneration

7.1.3.1.        Market Revenue and Forecast (2016-2030)

7.1.4.    Macular Edema

7.1.4.1.        Market Revenue and Forecast (2016-2030)

7.1.5.    Others

7.1.5.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Ophthalmic Photocoagulator Market, By Wavelength

8.1.  Ophthalmic Photocoagulator Market, by Wavelength, 2021-2030

8.1.1.    Green Scan Laser Photocoagulator

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Yellow Scan Laser Photocoagulator

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Red Scan Laser Photocoagulator

8.1.3.1.        Market Revenue and Forecast (2016-2030)

8.1.4.    Multicolor Scan Laser Photocoagulator

8.1.4.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Ophthalmic Photocoagulator Market, By End User

9.1.  Ophthalmic Photocoagulator Market, by End User, 2021-2030

9.1.1.    Hospitals

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Ambulatory Surgery Centers

9.1.2.1.        Market Revenue and Forecast (2016-2030)

9.1.3.    Ophthalmology Clinics

9.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Ophthalmic Photocoagulator Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, by Application (2016-2030)

10.1.2.  Market Revenue and Forecast, by Wavelength (2016-2030)

10.1.3.  Market Revenue and Forecast, by End User (2016-2030)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, by Application (2016-2030)

10.1.4.2.      Market Revenue and Forecast, by Wavelength (2016-2030)

10.1.4.3.      Market Revenue and Forecast, by End User (2016-2030)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, by Application (2016-2030)

10.1.5.2.      Market Revenue and Forecast, by Wavelength (2016-2030)

10.1.5.3.      Market Revenue and Forecast, by End User (2016-2030)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, by Application (2016-2030)

10.2.2.  Market Revenue and Forecast, by Wavelength (2016-2030)

10.2.3.  Market Revenue and Forecast, by End User (2016-2030)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, by Application (2016-2030)

10.2.4.2.      Market Revenue and Forecast, by Wavelength (2016-2030)

10.2.4.3.      Market Revenue and Forecast, by End User (2016-2030)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, by Application (2016-2030)

10.2.5.2.      Market Revenue and Forecast, by Wavelength (2016-2030)

10.2.5.3.      Market Revenue and Forecast, by End User (2016-2030)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, by Application (2016-2030)

10.2.6.2.      Market Revenue and Forecast, by Wavelength (2016-2030)

10.2.6.3.      Market Revenue and Forecast, by End User (2016-2030)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, by Application (2016-2030)

10.2.7.2.      Market Revenue and Forecast, by Wavelength (2016-2030)

10.2.7.3.      Market Revenue and Forecast, by End User (2016-2030)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, by Application (2016-2030)

10.3.2.  Market Revenue and Forecast, by Wavelength (2016-2030)

10.3.3.  Market Revenue and Forecast, by End User (2016-2030)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, by Application (2016-2030)

10.3.4.2.      Market Revenue and Forecast, by Wavelength (2016-2030)

10.3.4.3.      Market Revenue and Forecast, by End User (2016-2030)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, by Application (2016-2030)

10.3.5.2.      Market Revenue and Forecast, by Wavelength (2016-2030)

10.3.5.3.      Market Revenue and Forecast, by End User (2016-2030)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, by Application (2016-2030)

10.3.6.2.      Market Revenue and Forecast, by Wavelength (2016-2030)

10.3.6.3.      Market Revenue and Forecast, by End User (2016-2030)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, by Application (2016-2030)

10.3.7.2.      Market Revenue and Forecast, by Wavelength (2016-2030)

10.3.7.3.      Market Revenue and Forecast, by End User (2016-2030)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, by Application (2016-2030)

10.4.2.  Market Revenue and Forecast, by Wavelength (2016-2030)

10.4.3.  Market Revenue and Forecast, by End User (2016-2030)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, by Application (2016-2030)

10.4.4.2.      Market Revenue and Forecast, by Wavelength (2016-2030)

10.4.4.3.      Market Revenue and Forecast, by End User (2016-2030)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, by Application (2016-2030)

10.4.5.2.      Market Revenue and Forecast, by Wavelength (2016-2030)

10.4.5.3.      Market Revenue and Forecast, by End User (2016-2030)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, by Application (2016-2030)

10.4.6.2.      Market Revenue and Forecast, by Wavelength (2016-2030)

10.4.6.3.      Market Revenue and Forecast, by End User (2016-2030)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, by Application (2016-2030)

10.4.7.2.      Market Revenue and Forecast, by Wavelength (2016-2030)

10.4.7.3.      Market Revenue and Forecast, by End User (2016-2030)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, by Application (2016-2030)

10.5.2.  Market Revenue and Forecast, by Wavelength (2016-2030)

10.5.3.  Market Revenue and Forecast, by End User (2016-2030)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, by Application (2016-2030)

10.5.4.2.      Market Revenue and Forecast, by Wavelength (2016-2030)

10.5.4.3.      Market Revenue and Forecast, by End User (2016-2030)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, by Application (2016-2030)

10.5.5.2.      Market Revenue and Forecast, by Wavelength (2016-2030)

10.5.5.3.      Market Revenue and Forecast, by End User (2016-2030)

Chapter 11.  Company Profiles

11.1.              Lumenis

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              IRIDEX Corporation

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              Alcon Inc.

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              Quantel Medical

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              NIDEK CO., LTD.

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              Johnson & Johnson Vision Care, Inc.

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              TOPCON CORPORATION

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.              Bausch & Lomb Incorporated

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

11.9.              Meridian Medical Group

11.9.1.  Company Overview

11.9.2.  Product Offerings

11.9.3.  Financial Performance

11.9.4.  Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

Glossary of Terms

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38415

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com